Connect Biopharma Holdings Ltd ADR [CNTB] stock is trading at $1.17, up 8.27%. An important factor to consider is whether the stock is rising or falling in short-term value. The CNTB shares have gain 20.48% over the last week, with a monthly amount glided 44.18%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Connect Biopharma Holdings Ltd ADR [NASDAQ: CNTB] stock has seen the most recent analyst activity on June 12, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $7. Previously, H.C. Wainwright started tracking the stock with Buy rating on March 04, 2024, and set its price target to $7. On April 13, 2021, SVB Leerink initiated with a Outperform rating and assigned a price target of $32 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating. Jefferies initiated its recommendation with a Buy and recommended $27 as its price target on April 13, 2021.
Connect Biopharma Holdings Ltd ADR [CNTB] stock has fluctuated between $0.51 and $1.60 over the past year. Currently, Wall Street analysts expect the stock to reach $1.5 within the next 12 months. Connect Biopharma Holdings Ltd ADR [NASDAQ: CNTB] shares were valued at $1.17 at the most recent close of the market. An investor can expect a potential return of 28.21% based on the average CNTB price forecast.
Analyzing the CNTB fundamentals
Gross Profit Margin for this corporation currently stands at 0.97% with Operating Profit Margin at -0.68%, Pretax Profit Margin comes in at -0.59%, and Net Profit Margin reading is -0.6%. To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.15 and Total Capital is -0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0862 points at the first support level, and at 1.0031 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.2262, and for the 2nd resistance point, it is at 1.2831.
Ratios To Look Out For
For context, Connect Biopharma Holdings Ltd ADR’s Current Ratio is 10.25. On the other hand, the Quick Ratio is 10.25, and the Cash Ratio is 9.25. Considering the valuation of this stock, the price to sales ratio is 2.49, the price to book ratio is 0.78.
Transactions by insiders
Recent insider trading involved Wei Zheng, 10% Owner, that happened on Jun 11 ’25 when 39775.0 shares were purchased.
